Similar to the case in B-cell neoplasms, MYC is one of the key downstream target genes of IRF4 in several mature T-cell neoplasms, including ALCL [91] and ATL cells [82,92]. The gene discussed is IRF4; the disease is anaplastic large cell lymphoma.